Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N = 105, ages 7–13 years, mean age 10.8 ± 1.8 years) were enrolled at nine centers (eight in the United States and one in Israel) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Forlenza, Gregory P., Pinhas-Hamiel, Orit, Liljenquist, David R., Shulman, Dorothy I., Bailey, Timothy S., Bode, Bruce W., Wood, Michael A., Buckingham, Bruce A., Kaiserman, Kevin B., Shin, John, Huang, Suiying, Lee, Scott W., Kaufman, Francine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350071/
https://www.ncbi.nlm.nih.gov/pubmed/30585770
http://dx.doi.org/10.1089/dia.2018.0264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350071/
https://www.ncbi.nlm.nih.gov/pubmed/30585770
http://dx.doi.org/10.1089/dia.2018.0264

Ejemplares similares